Home › Trial NCT00850785
Autologous Tumor DRibble Vaccine in Patients With Non-Small Cell Lung Cancer
- Trial IDNCT00850785
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorProvidence Health & Services
- Enrollment6
- Start date2009-01
- ConditionsNon Small Cell Lung Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.